Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. - Wikidata - awgldk - TriplyDB

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

http://www.wikidata.org/entity/Q40057653

about

Roles of lipoprotein receptors in the entry of hepatitis C virus Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles Hepatitis C Virus entry: the early steps in the viral replication cycle Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics Involvement of Ceramide in the Propagation of Japanese Encephalitis Virus Viruses and tetraspanins: lessons from single molecule approaches.The SR-BI partner PDZK1 facilitates hepatitis C virus entry.Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus Hepatitis C virus life cycle and lipid metabolism Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection.Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections Morphogenesis of infectious hepatitis C virus particles Up-regulation of Plasma Hexosylceramide (d18: 1/18: 1) Contributes to Genotype 2 Virus Replication in Chronic Hepatitis C: A 20-Year Cohort Study Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.Cellular and molecular biology of HCV infection and hepatitis.CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.Role of lipid metabolism in hepatitis C virus assembly and entry.Exploitation of lipid components by viral and host proteins for hepatitis C virus infection.Iminosugar antivirals: the therapeutic sweet spot.Sphingosine kinase 2 is a chikungunya virus host factor co-localized with the viral replication complex.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.Role of sulfatide in vaccinia virus infection.Function of membrane rafts in viral lifecycles and host cellular response Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels.Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection.Sphingosine kinase 1 regulates measles virus replication.Hepatitis C virus: Morphogenesis, infection and therapy.HCV Receptors and Virus Entry

P2860

Q26777338-B718BADE-13B5-43CC-A4FF-2F58DEB691AD Q26864485-9E560CE0-4BBE-464A-A37D-A3A9243D2148 Q27486112-74E7824D-602D-48C7-91B8-E80BE9E5602D Q27488727-D943158D-5547-45B7-9429-0A734D60DDB8 Q27489056-05A66F67-18E5-41C2-B750-1151ED760457 Q27489242-B58B2481-DEB9-48C3-AFD8-4B0F20FDC72D Q27490520-87F34C44-11EE-4C8A-8992-1CD764BC3178 Q27490958-CCAE5FC0-6C8E-41F8-AF87-55DCB8518689 Q33677540-CBBF2BCF-7BE1-423F-BFDC-9081BE78A3CD Q33719403-5F52D3A3-6209-4B4F-BA5A-E727561438C1 Q34084050-B803C550-24BC-48F6-BF0F-323E781AC7D9 Q34792436-43346538-77D4-4963-8368-CDAA4A141543 Q35020246-49C38D1F-6AEA-4B5C-918B-0435C048C54C Q35115534-4B0D4A77-E12A-49CE-B164-A7DAF366FE17 Q35472380-828FCDCE-C981-4DBE-A566-A36995B78C7B Q35740670-D4380C86-C9C5-41CB-9F3B-42F2F452A10A Q37003642-22A2ADE4-D8AF-48DB-BCE9-D2873D2663C7 Q37015738-00605A71-5D15-40D3-9B15-A2A91F9A7CF3 Q37514366-092E1F12-534E-440A-926E-065184561280 Q37611842-335C9C76-1C89-49F9-B886-A70AECF67098 Q37621569-703C57DE-FF59-450E-8ADE-44F4D3B5809D Q37986051-CD192898-14F9-4B3C-9D24-98B9EEA87E11 Q38730551-278CA70A-5CBA-40B7-AC6D-DA5FF4A2B056 Q38818977-F4A9F788-86F0-4BE7-AFE9-5C58B1129FDC Q38833111-7FDDEEF2-97F6-475A-9EA9-F98C63984513 Q39303797-64EAFE66-DB2D-42D8-9445-A01E8B594090 Q39545996-60A79880-77C9-4B9C-96A2-36E1C225C795 Q39724559-DFFB2EA4-7897-4F03-AA39-0AAB446C15E1 Q40700090-F5D32D8B-0B3F-48CE-961A-B094B6CEDE90 Q41687237-F6BE6E2D-5CAF-4CE2-BB18-04D899C9D325 Q41934199-A5A8EA5F-A4AE-42FC-AAFE-F934972EC8FB Q52661702-536336C4-841F-4616-B0FA-91B8D165D01F Q57564402-9B0665D3-D94B-4F80-87E2-D5B9C0A5E13A

P2860

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

http://www.wikidata.org/entity/Q40057653

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Ceramide enrichment of the pla ...... ibits hepatitis C virus entry.

@en

type

label

Ceramide enrichment of the pla ...... ibits hepatitis C virus entry.

@en

prefLabel

Ceramide enrichment of the pla ...... ibits hepatitis C virus entry.

@en

P1433

Q40057653-BD3FA07E-2669-4CDB-983C-87122C69C91E

P1476

Q40057653-47C844BE-D0ED-49AD-8753-F693C0DE8EB1

P2093

Q40057653-142CA53C-69C3-40C2-BD26-3CFDC4E30AEC

Q40057653-6EA06E1C-E471-4194-9E40-D8CBDA540D19

Q40057653-7C47A489-1C62-4CA4-81F5-A99BA08FC03F

Q40057653-9AD7ED88-2F1D-47BB-AD2A-2639C22E5E72

Q40057653-BD0D4D67-DE33-4412-AC3B-06B0D7A2A57E

Q40057653-E67BA5F8-4711-4E53-A8AF-B16EEEDCCCBC

P2860

Q40057653-04247681-9AFF-4219-AC1A-EB4D842DF334

Q40057653-062E71A1-F837-4FDD-B9BD-540ADB8BBC92

Q40057653-1572F3B2-E0E6-43A3-95C1-278AE4B94FDD

Q40057653-177D6EA4-40C7-48AB-8454-BA1EFD32A998

Q40057653-190D130B-DB3F-45AC-9BD7-FB2D01057E3F

Q40057653-1CC0333D-B137-4F05-8A99-23F999652F87

Q40057653-2ABA78EA-6840-422F-8E03-0DBD0C4070FC

Q40057653-2BB47378-E5B1-4033-A09D-5D6364F988D5

Q40057653-2EC21D64-1F04-46A7-A75C-C04CE45FB32E

Q40057653-3594B679-1A45-477F-BAD1-65F1AC57AE1B

P304

Q40057653-6F19DD1D-24B3-41F1-8C54-9F90BE234D3B

P31

Q40057653-82EF1506-789B-4295-AFAF-6C9036119BD8

P356

Q40057653-02AC00DF-C81B-4784-B5DE-906C4AB8E962

P433

Q40057653-D95E1237-218A-4BCB-8A8D-B54E2CCD3878

P478

Q40057653-C179B5CE-0FDE-4800-9CCB-C7C02D8F329F

P50

Q40057653-217702C9-4231-4F61-B55E-F9C98EDDA8B7

Q40057653-4882F8B2-EDF9-4EAE-A4B6-4322B086A9AF

Q40057653-80A36129-55B4-4A8D-AA03-B4617C14DD4B

Q40057653-8F9C8A8B-675F-4767-928B-5A0233B9FF24

Q40057653-C34A0C54-20D6-4EB3-BF9A-795E888D6585

P577

Q40057653-87F7F29A-0021-4261-A6CC-D8982A13FBF8

P5875

Q40057653-63E62DC8-6ADE-4DEC-AFEF-A59588182B62

P698

Q40057653-529C2006-6515-4A98-A422-D0C2DCDDDED8

P356

J.1462-5822.2007.01070.X

P1433

Cellular Microbiology

P1476

Ceramide enrichment of the pla ...... hibits hepatitis C virus entry

@en

P2093

Angéline Bilheu

http://www.w3.org/2001/XMLSchema#string

Anne Op De Beeck

http://www.w3.org/2001/XMLSchema#string

Czeslaw Wychowski

http://www.w3.org/2001/XMLSchema#string

Cécile Voisset

http://www.w3.org/2001/XMLSchema#string

Justine Bertrand-Michel

http://www.w3.org/2001/XMLSchema#string

Ngoc Vu-Dac

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

Robust hepatitis C virus infection in vitro.

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle Entry

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

P304

606-617

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1462-5822.2007.01070.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

François Tercé

P577

2007-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5866618

http://www.w3.org/2001/XMLSchema#string

P698

17979982

http://www.w3.org/2001/XMLSchema#string